Thermo Fisher has recently earned a Buy rating from Wells Fargo with a $570 target, citing its strong healthcare position.

Imugene is tapping the market for up to $35 million, while Clever Culture Systems and Compumedics are soaring on positive ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 11, Scotiabank ...

Fintel reports that on July 11, 2025, Scotiabank upgraded their outlook for Thermo Fisher Scientific (NYSE:TMO) from Sector ...

U.S. Food safety testing Market Size, Share, Competitive Landscape & Trend Analysis Report, by Type, By Food Tested and ...

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

During the last three months, 13 analysts shared their evaluations of Thermo Fisher Scientific TMO -0.25% Get Free Report , ...

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

Thermo Fisher Scientific announced a quarterly dividend of $0.43 per share, continuing a 14-year streak of payouts. The ...

North Carolina finished third in the economy category and fourth in business friendliness. The network scored each state on ...

Gov. Josh Stein and a national media outlet appeared at the Battleship North Carolina Thursday morning to make the ...

Thermo Fisher Scientific Inc. closed 31.40% below its 52-week high of $627.88, which the company achieved on September 10th.